Heart and Kidney Complications in Systemic Sclerosis: The Role of Natriuretic Peptides
Systemic sclerosis patients face overlapping cardiac and renal complications, with natriuretic peptides serving as key biomarkers for assessing cardiorenal involvement.
Quick Facts
What This Study Found
Cardiorenal involvement is a major driver of morbidity and mortality in systemic sclerosis, with CKD commonly present at PAH diagnosis and independently associated with mortality.
Key Numbers
Reviews troponin, BNP, NT-proBNP, creatinine, cystatin C, NGAL, and galectin-3 as cardiorenal biomarkers in SSc. Type 2 cardiorenal syndrome (CKD from chronic HF) discussed.
How They Did This
Review article examining cardiac and renal complications in systemic sclerosis, focusing on biomarker assessment including natriuretic peptides.
Why This Research Matters
SSc patients often have overlapping organ damage that is difficult to untangle. Recognizing the cardiorenal connection and using appropriate biomarkers can improve risk stratification and treatment timing.
The Bigger Picture
The cardiorenal axis is increasingly recognized as critical in autoimmune diseases. Understanding how heart and kidney damage interact in SSc could improve management of other autoimmune conditions as well.
What This Study Doesn't Tell Us
Review article — does not present new clinical data. SSc is heterogeneous, and cardiorenal involvement varies significantly between patients.
Questions This Raises
- ?Should SSc patients be routinely screened for subclinical kidney disease at PAH diagnosis?
- ?Can early intervention targeting both cardiac and renal pathways improve SSc outcomes?
Trust & Context
- Key Stat:
- CKD independently linked to mortality Chronic kidney disease is common in systemic sclerosis patients with pulmonary arterial hypertension and independently predicts worse outcomes
- Evidence Grade:
- Review article synthesizing existing literature on cardiorenal involvement in SSc. Provides clinical framework but no new data.
- Study Age:
- Published in 2025, reflecting current understanding of cardiorenal interactions in systemic sclerosis.
- Original Title:
- Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients.
- Published In:
- Biomolecules, 15(9) (2025)
- Authors:
- Pellicano, Chiara, D'Ippolito, Giancarlo, Villa, Annalisa, Martellucci, Ottavio, Basile, Umberto, Carnazzo, Valeria, Basile, Valerio, Rosato, Edoardo, Marino, Mariapaola, Gigante, Antonietta
- Database ID:
- RPEP-13007
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
Why do systemic sclerosis patients develop heart and kidney problems?
SSc causes blood vessel damage and fibrosis (scarring) throughout the body. In the lungs, this leads to pulmonary arterial hypertension, which overloads the right side of the heart. The same vascular damage affects the kidneys, and the two organ systems worsen each other in a vicious cycle.
What role do natriuretic peptides play in SSc monitoring?
BNP and NT-proBNP blood tests help doctors assess how much stress the heart is under. In SSc patients, these biomarkers can help detect cardiac involvement early and guide decisions about treatment intensity.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13007APA
Pellicano, Chiara; D'Ippolito, Giancarlo; Villa, Annalisa; Martellucci, Ottavio; Basile, Umberto; Carnazzo, Valeria; Basile, Valerio; Rosato, Edoardo; Marino, Mariapaola; Gigante, Antonietta. (2025). Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients.. Biomolecules, 15(9). https://doi.org/10.3390/biom15091297
MLA
Pellicano, Chiara, et al. "Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients.." Biomolecules, 2025. https://doi.org/10.3390/biom15091297
RethinkPeptides
RethinkPeptides Research Database. "Assessment of Cardiorenal Involvement in Systemic Sclerosis ..." RPEP-13007. Retrieved from https://rethinkpeptides.com/research/pellicano-2025-assessment-of-cardiorenal-involvement
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.